ArticleRadiology case reports2026
When size misleads: CT attenuation and enhancement characteristics predict benignity in a giant ovarian mucinous cystadenoma.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant ovarian cysts are uncommon due to widespread early imaging detection; however, when encountered-particularly in perimenopausal women-they raise significant concern for malignancy. We report a 53-year-old woman presenting with progressive abdominal distension and 4 months of amenorrhea. Ultrasound demonstrated a 27 cm cystic adnexal mass with internal debris, categorized as O-RADS US 3. Contrast-enhanced CT showed a well-circumscribed cyst with homogeneous near-water attenuation (0-4 Hounsfield units), no enhancement, and no solid components, ascites, or lymphadenopathy-features demonstrating benign imaging characteristics analogous to O-RADS 2. Serum tumor markers (CA-125 15.9 U/mL, CEA 0.999 ng/mL, AFP 1.21 ng/mL, β-hCG < 0.2 mIU/mL, and LDH 215 U/L) were overall within or near normal limits. The patient underwent staging laparotomy, and histopathology confirmed benign mucinous cystadenoma with reactive changes in lymph nodes, omentum, and peritoneal biopsies. This case highlights that near-water CT attenuation and absence of enhancement are strong predictors of benignity even in extremely large adnexal masses, and that lesion size alone should not be considered a surrogate marker for malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.